Mot de passe
Afficher le mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 


SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur REGENERON PHARMACEUTICALS
25/10ZAI LAB : Says First Patient Treated in China Portion of Global Study of Odronextamab for ..
25/10REGENERON PHARMACEUTICALS : Second dupixent (dupilumab) phase 3 eosinophilic esophagitis t..
25/10SANOFI : Regeneron's Second Late-Stage Inflammatory Disease Trial Meets Primary Endpoints
25/10SANOFI : Regeneron's Dupixent Improves Swallowing in Late-Stage Study
25/10REGENERON PHARMACEUTICALS : Second Dupixent® (dupilumab) Phase 3 Eosinophilic Esophagitis ..
22/10COVID : Comm.Ue definisce portafoglio delle 10 cure più promettenti
22/10MIDDAY BRIEFING - Unternehmen und Märkte -2-
22/10REGENERON/SANOFI : Dupixent erreicht wichtige Endpunkte bei Prurigo Nodularis
22/10SANOFI : Regeneron's Dupixent Meets Primary, Key Secondary Endpoints in Phase 3 Trial in P..
22/10REGENERON, SANOFI : Dupixent Hits Main Endpoints in Prurigo Nodularis Trial
22/10SANOFI : Regeneron's Dupixent Cuts Itch in Late-Stage Skin Disease Study
21/10REGENERON PHARMACEUTICALS : Fda expands approval of dupixent (dupilumab) to include childr..
21/10SANOFI : Regeneron Win Expanded US FDA Nod for Asthma Drug Dupixent
20/10REGENERON PHARMACEUTICALS : Sanofi Say FDA Has Expanded Approval of Dupixent to Include Ch..
20/10REGENERON PHARMACEUTICALS : FDA Expands Approval of Dupixent® (dupilumab) to Include Child..
14/10REGENERON PHARMACEUTICALS : FDA Accepts Regeneron's 'Regen-Cov" For Priority Review for Tr..
14/10Health Care Stocks Climb Pre-Bell Thursday
14/10REGENERON PHARMACEUTICALS : US FDA Accepts Regeneron's Regen-Cov For Priority Review for C..
14/10REGENERON PHARMACEUTICALS : FDA Accepts Regeneron's 'Regen-Cov" For Priority Review for Tr..
14/10REGENERON PHARMACEUTICALS : FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priorit..
14/10Regeneron Cocktail Gets FDA Priority Review for Covid-19 Treatment, Prevention
11/10REGENERON PHARMACEUTICALS : to Report Third Quarter 2021 Financial and Operating Results a..
11/10EU-Arzneimittelbehörde prüft Zulassung von Corona-Medikament
11/10EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation
11/10REGENERON PHARMACEUTICALS : EU assesses Regeneron/Roche COVID-19 antibody cocktail for aut..
11/10ROCHE : Ema avvia valutazione per ok a Ronapreve in cura e prevenzione Covid
11/10REGENERON PHARMACEUTICALS : Merck seeks first U.S. authorization for COVID-19 pill
11/10AstraZeneca antibody cocktail study shows success treating COVID-19
08/10Govt to control distribution of GSK/Vir COVID-19 antibody in U.S. - FDA
07/10ROCHE : Philippine Drug Regulator OKs Roche-Regeneron's COVID-19 Antibody Cocktail
05/10Amgen's 'Underappreciated' Inflammation Portfolio Set to Trigger Growth, RBC Capital An..
04/10INSIDER SELL : Regeneron Pharmaceuticals
01/10CLOSE UPDATE : US Stocks Rebound Friday Amid Resilient Economic Data, Excitement Over Merc..
01/10Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
01/10US Stocks Rebound Friday Amid Resilient Economic Data, Excitement Over Merck's COVID-19..
01/10Regeneron Pharmaceuticals Down Over 5%, on Pace for Largest Percent Decrease Since Marc..
01/10REGENERON PHARMACEUTICALS : New regen-cov (casirivimab and imdevimab) data show supportive..
30/09GLOBAL MARKETS LIVE : Boeing, Walgreens, Dufry, M&S, Novartis...
30/09REGENERON PHARMACEUTICALS : New england journal of medicine publishes positive phase 3 tri..
30/09REGENERON PHARMACEUTICALS : Says COVID-19 Drug Reduces Viral Load In Mid-Stage Trial
30/09Regeneron Covid-19 Trial Meets Primary Endpoint
30/09¿Un verano para nada?
30/09Regeneron Pharmaceuticals, Inc. Announces a Trial Assessing Investigational REGEN-COV™ ..
29/09REGENERON PHARMACEUTICALS : Phase 3 Study Shows REGEN-COV Reduced Death, Hospitalization b..
29/09REGENERON PHARMACEUTICALS : Fda accepts libtayo (cemiplimab-rwlc) for priority review for ..
28/09Health Care Stocks Decline Premarket Tuesday
28/09REGENERON PHARMACEUTICALS' : Libtayo Accepted for Priority Review by FDA; Shares Down Pre-..
28/09REGENERON PHARMACEUTICALS : FDA Accepts Libtayo® (cemiplimab-rwlc) for Priority Review for..
28/09U.S. Food and Drug Administration Accepts Biologics License Application of Regeneron Ph..
28/09Regeneron Gets FDA Priority Review of Libtayo in Advanced Cervical Cancer
24/09REGENERON PHARMACEUTICALS : Welcomes World Health Organization Recommendation for Use of R..
24/09REGENERON PHARMACEUTICALS : WHO backs Regeneron COVID-19 drug cocktail as UN body calls fo..
22/09REGENERON PHARMACEUTICALS : New dupixent (dupilumab) data in patients as young as six year..
22/09Fed verdict is imminent
22/09ANALYST RECOMMENDATIONS : Blackstone, Burberry, FedEx, Hershey, Micron Technology...
21/09EU signs joint procurement deal for Eli Lilly COVID-19 treatment
21/09REGENERON PHARMACEUTICALS : New Dupixent® (dupilumab) Data in Patients as Young as Six Yea..
20/09REGENERON PHARMACEUTICALS : Esmo late-breaking data show libtayo (cemiplimab) and chemothe..
20/09SANOFI : - ESMO late-breaking data show Libtayo (cemiplimab) and chemotherapy first-line t..
20/09Biogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
20/09SANOFI : Regeneron, Sanofi Say Lung Cancer Drug Libtayo Improves Overall Patient Survival ..
20/09SANOFI : Regeneron's Libtayo Combo Extends Lung Cancer Patients' Lives In Phase 3 Study
17/09INSIDER SELL : Regeneron Pharmaceuticals
16/09REGENERON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form 8-K)
16/09Regeneron Pharmaceuticals, Inc. Enters into Supply Agreement with Army Contracting Comm..
15/09INSIDER SELL : Regeneron Pharmaceuticals
15/09REGENERON PHARMACEUTICALS : Announces new u.s. government agreement to purchase additional..
15/09CORONA-BLOG/Patientenschützer gegen Ende der Lohnfortzahlung
15/09Yes, the global economic recovery is slowing
15/09CORONA-BLOG/PFIZER : Daten zu Covid-Vakzin bei Kindern Ende September
15/09CORONA-BLOG/US-Regierung kauft Medizin von Regeneron für 2,9 Mrd USD
15/09REGENERON PHARMACEUTICALS : U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 th..
15/09ROCHE : To Continue Developing COVID-19 Therapies, Diagnostics Amid Endemic Possibility
15/09REGENERON PHARMACEUTICALS : US Orders 1.4 Million Additional Doses of COVID-19 Antibody fr..
1  2  3  4  5  6  7  8  9  10Suiv.